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Abst rac t
Background and purpose: Percutaneous vertebroplasty (PVP)
is a minimally invasive vertebral augmentation procedure for
the treatment of recent, osteoporotic vertebral compression
fractures. The aim of the study was to determine the early and
late outcomes of PVP for osteoporotic vertebral compression
fractures.
Material and methods: We prospectively assessed outcomes of
PVP in 200 patients with single, osteoporotic vertebral compre s-
sion fracture. Follow-up assessment was made 12 hours after
surgery as well as after 7 days, 30 days, 3 months, 6 months,
and 1 year after surgery. A subgroup of 80 patients was eva-
luated also 2 years after PVP. A 100-mm visual analogue sca-
le of pain was used for outcome measurement.
Results: Twelve hours after PVP, very significant relief of pain
was obtained in 85% of patients; on the 7th and 30th day a very
good result of treatment was noted in 96%. The same result
was noted in 92% of patients at the 6th month, and in 90% of
patients at the 12th month. Among the 80 patients followed
for 2 years, 3 patients reported recurrence of pain and were
subsequently diagnosed with new osteoporotic fractures.
Conclusions: Percutaneous vertebroplasty is a minimally inva-
sive method of treatment for fresh osteoporotic fractures,
which provides a significant and sizeable reduction of pain in
the short as well as long term after surgery. Complete relief
of pain was noted 12 hours after PVP in 94% of patients, and
was noted in 90% two years after treatment. Despite some
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St reszczenie
Wstêp i cel pracy: Wertebroplastyka jest szeroko stosowan¹,
minimalnie inwazyjn¹ metod¹ leczenia œwie¿ych kompresyj-
nych z³amañ osteoporotycznych trzonów krêgów. Celem pra-
cy by³a ocena wczesnych i odleg³ych wyników leczenia œwie -
¿ych z³amañ osteoporotycznych trzonów krêgów za pomoc¹
przezskórnej wertebroplastyki.
Materia³ i metody: Prospektywnej analizie poddano 200 pa -
cjentów leczonych za pomoc¹ wertebroplastyki z powodu
pojedynczego, osteoporotycznego z³amania trzonu krêgu.
Stan pacjentów oceniano 12 godz. po zabiegu, po up³ywie 
7 dni, miesi¹ca, 3 miesiêcy, 6 miesiêcy i 12 miesiêcy, a 80 pa -
 cjentów oceniono tak¿e po up³ywie 24 miesiêcy. Wynik by³
oceniany przy u¿yciu 100-milimetrowej wzrokowej analogo-
wej skali oceny bólu.
Wyniki: Po 12 godz. po zabiegu ust¹pienie dolegliwoœci lub
istotn¹ poprawê zanotowano u 85% pacjentów, w 7. i 30. dniu
bardzo dobre wyniki stwierdzono u 96% pacjentów. Po 6 mie-
si¹cach bardzo dobry wynik utrzymywa³ siê u 92%, a po 
12 miesi¹cach – u 90% leczonych. Spoœród 80 pacjentów
obserwowanych po 2 latach nawrót dolegliwoœci bólowych
wyst¹pi³ tylko u 3 pacjentów, u których dosz³o do z³amania
kolejnego trzonu krêgu.
Wnioski: Wertebroplastyka jest minimalnie inwazyjn¹ metod¹
leczenia œwie¿ych z³amañ osteoporotycznych, pozwalaj¹c¹ na
uzyskanie bardzo dobrych wyników leczenia, zarówno wczes-
nych, jak i póŸnych. Ca³kowite ust¹pienie dolegliwoœci obser-
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Introduction
Duration of life continues to increase, which leads to
an increased number of patients with osteoporotic frac-
tures, proximal femur and vertebrae being the most of-
ten noted. Vertebral compression fractures cause signif-
icant pain and some patients are debilitated by the pain
due to the fracture [1-3]. Conventional surgery carries
a high risk and poor outcomes and is reserved only for
patients with significant neurological deficit [2,3]. Ver-
tebroplasty involves the injection of liquid polymethyl-
methacrylate (PMMA) cement through a needle into the
vertebral body, where it becomes hard, restores stabili-
ty and diminishes pain [3-7]. This me thod of treatment
is relatively safe, causing minimal operative trauma, and
complications are rare [4,8], mainly caused by ex-
travertebral leakage of the cement [2-4] or osteitis [9].
In 2009, two randomized trials of vertebroplasty for os-
teoporotic spinal fractures did not find a beneficial effect
of vertebroplasty as compared to conservative treatment
[1,10]. Conclusions from both trials are doubtful; 
the first one, from Australia [1], included 78 participants
(35 treated by vertebroplasty and 36 without cement 
augmentation); the second one [10], from Mayo Clin-
ic, involved 131 patients (68 treated by vertebroplasty and
63 without surgery). The number of patients included
in both trials is not large, and it requires further studies,
with a larger group of observed patients [6,11-13]. 
Compression fractures can also be treated by ky-
phoplasty, in which an inflated balloon increases the 
height of the broken vertebra, correcting the kyphotic de-
formation [2,5,9]. Both methods – vertebroplasty and
kyphoplasty – show similar clinical results [2,5,14]. Re-
cently, radiofrequency methods have been used for pain
treatment in osteoporotic fractures with promising results
[12,14]. Some authors suggest that augmentation of one
vertebra can increase the probability of new fractures de-
veloping in adjacent vertebrae [15,16]. In osteoporosis,
we often face the problem of multiple fractures, and 
about 20% of patients with previously diagnosed single
compression fracture develop new ones [3,14,16].
Some authors even suggest prophylactic augmentation
of decalcified vertebrae [14]. The development of frac-
tures increases mortality [2,10]; it should also be noted
that almost 4% of fractures are due to neoplastic disease,
which suggests the value of vertebral biopsy, which 
could be performed during this procedure [3,12]. In pa-
tients with pathological fractures due to malignant 
tumours of the vertebrae, vertebroplasty also gives satis -
factory results [3,5,13].
In this paper, we analysed the results of treatment of
single compression osteoporotic vertebral fractures by ce-
ment vertebral augmentation. 
Material and methods
Two hundred consecutive patients with single os-
teoporotic vertebral fracture were included in the study.
The patients were treated surgically between June 2007
and June 2009. There were 178 women and 22 men stud-
ied, and their age ranged between 58 and 89 years (114
patients were 70-80 years old). One hundred and forty-
two (71%) patients had a thoracic fracture and 
58 (29%) had a lumbar fracture. The highest fracture was
located at Th3, and the lowest one at L5 level. 
The time from the onset of pain to surgery was 1 week
to 7 months (mean: 4 weeks).
All the fractured vertebrae were augmented with 
an acrylic cement (Vertaplex, Stryker, USA). Surgical pro-
cedures were performed under local anaesthesia, 
and a unilateral transpedicular approach was used 
(Figs. 1-3). A normal 10-cm3 syringe was used for ap-
plication of the cement. We did not use any application
systems manufactured for vertebroplasty. The amount of
PMMA injected depended on the height of the com-
pressed vertebral body and ranged from 1 cm3 at the up-
per thoracic level to 3.5 cm3 in the lower lumbar part of
the vertebral column. The results of treatment were eval-
literature data suggesting no beneficial effect of PVP, it can
be concluded that PVP is the most effective and the safest
method for fresh vertebral compression fracture treatment.
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wowano ju¿ po 12 godz. u 94% chorych, taki wynik utrzy-
mywa³ siê przez kolejne dwa lata u 90% leczonych. Mimo
pojedynczych doniesieñ o nieskutecznoœci tej metody wyda-
je siê, ¿e w œwie¿ych z³amaniach osteoporotycznych werte-
broplastyka jest najskuteczniejsz¹ i najbezpieczniejsz¹ metod¹
leczenia dolegliwoœci bólowych, bêd¹cych wynikiem z³amañ
trzonów krêgów.
S³owa kluczowe: osteoporoza, z³amanie trzonu krêgu, wer-
tebroplastyka.
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Early and long-term outcomes of vertebroplasty
uated on the 1st, 7th and 30th day, as well as 3 months, 
6 months and 12 months after surgery. In 80 patients, the
results were also evaluated 2 years after performing ver-
tebroplasty. For evaluation of pain, a 100-mm visual ana-
logue scale was used [17,18].
Results
There were no intraoperative complications. The leak-
age of small amounts of PMMA outside the vertebral
body was noted in 8 patients, including leakage into the
intervertebral space in 2 patients, and anteriorly to the
vertebral body in 6 other patients. There were no clini-
cal symptoms of leakage in any of those patients.
Just before surgery, the level of pain ranged between
56 and 100 mm (mean: 78 mm). On the first day after
surgery, very significant relief of pain was noted in 
170 (85%) patients; the mean value on the visual ana-
logue scale in those 170 patients diminished to 22 mm
and 101 patients (50%) were free of pain. Twenty patients
noted only slight improvement, i.e. a change less than 
10 mm, and in 10 patients the level of pain did not change.
The same results were noted on the 7th day. The mean
value of pain severity in the whole group of 200 patients
was 29 mm on the visual analogue scale. On the 30th day,
the pain diminished significantly in 12 of the 20 patients
Fig. 1. Plain X-ray, lateral view. Compression fracture of L1 vertebral body
Fig. 2. Intraoperative plain X-ray, lateral view. The needle is inserted trans-
pedicularly. PMMA is injected into the vertebral body
Fig. 3. Plain X-ray, lateral view. The compressed vertebral body is augmen-
ted with PMMA
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with only a slight improvement after surgery (the mean
pain severity among these patients changed from 52 to
34 mm on the visual analogue scale) and the value for
the whole group dimi nished to 27 mm. All the patients
who did not benefit from PVP were treated later than 
3 months after the onset of pain.
The follow-up performed 3 and 6 months after
surgery revealed results similar to those noted one
month after vertebroplasty. One-year follow-up re-
vealed that 21 patients, who were earlier free of pain, re-
ported the recurrence of symptoms, with the mean val-
ue of 36 mm on the visual analogue scale (i.e. less than
before sur gery). In one of these patients a new fracture
appeared, but not in the vertebra adjacent to the previ-
ously augmented one.
Eighty patients were examined two years after
surgery. The mean pain severity in this group was 38 mm
on the visual analogue scale. Results of treatment were
the same as one year after surgery, except for three pa-
tients, who developed new osteoporotic fractures, one of
them in a vertebra adjacent to the previously augment-
ed one. Performing the next procedure resulted in total
relief of pain in these 3 patients.
Discussion
Percutaneous vertebroplasty is widely used for the
treatment of osteoporo tic compressed fractures of the ver-
tebrae [2-4,7,9,13,15]. Recently, two randomized trials
put into doubt the efficiency of vertebroplasty in osteo-
porotic fractures [1,10], but a number of different se-
ries of patients show signi ficant relief of pain after per-
forming this procedure [3-5,7,12-14]. Some authors
suggested an increase of the number of new fractures af-
ter performing vertebroplasty [15,16], especially in ver-
tebrae adjacent to the augmented ones [15]. In our pa-
tients, we noted the development of new fractures
during one-year follow-up in 1 of 200 patients only. Two
years after surgery, however, new fractures developed in
3 of 80 examined patients, but only one patient had a frac-
ture in a vertebra adjacent to the previously augmented
one. The de ve lopment of new fractures seems to be in-
dependent of augmentation.
Vertebroplasty is a relatively safe method of treatment
with a small number of complications. The commonest
one is extravertebral leakage outside the vertebral body.
However, it does not produce any clinical symptoms. In
1-2% of cases, PMMA leaks into the vertebral canal,
which can produce radicular or spinal deficits, from pain
to paresis, possibly requiring open surgical intervention
and decompression of the spine [4,8,9]. Very rare sys-
temic complications consist of pulmonary embolism and
severe haemorrhage caused by the puncture of the big
vessels during vertebroplasty [8,9]. Kyphoplasty gives
a lower incidence of complications than vertebroplasty,
but in osteoporotic fractures clinical results of both meth-
ods are similar [2,5,14]. Kyphoplasty requires a bilateral
transpedicular approach. The procedure lasts much
longer, which is very uncomfortable for the patients, and
the costs are much higher. The authors routinely perform
kyphoplasty in trauma tic fractures and in some patients
with pathological fractures caused by vertebral body neo-
plasms, but we do not find any advantages of kyphoplasty
versus vertebroplasty in patients with osteoporosis.
We did not note any important complications of PVP.
In 6 cases (3%), an outside leakage of cement was seen
but it did not cause any clinical symptoms. This confirms
the opinions of other authors [4,7,8] that the complication
rate for this procedure is low. Some reviews show high
rates of cement leakage, up to 40%, but it mainly depends
on the amount of cement injected, as well as on the ce-
ment viscosity. We use PMMA of high viscosity and in-
ject no more than 3 cm3, which significantly reduces ce-
ment leakage. With the development of new types of
cement, especially hydroxyapatite, vertebroplasty should
become safer and lead to physiolo gical healing of the frac-
tures. Recently, we have also performed several procedures
using hydroxyapatite, but it needs time to check the ef-
ficiency of such cement. We do not find any advantages
of specially designed application systems in comparison
to the typical syringe, similarly to other authors [2,4,15].
The results of our study show a significant reduc-
tion in pain levels – 50 mm reduction on the 100-mm
scale. This reduction of pain persisted 1 and 2 years af-
ter vertebroplasty. Satisfactory results were obtained in
85% of patients; 10% showed only slight reduction of
pain level, and in 5% of patients no improvement was
noted. It is difficult to say which patients have no ben-
eficial effect of vertebroplasty, but some literature data
show that the best results are obtained in patients with
recent fractures. In all our patients who did not improve,
the time interval between the onset of pain and PVP ex-
ceeded 3 months, which supports these observations.
Conclusions
1. Vertebroplasty provides significant reduction in pain,
use of analgesics, and disability both in the short and
long term.
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2. The procedure is relatively safe and the number of com-
plications is low.
3. Vertebroplasty does not increase the risk of new ver-
tebral fractures.
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